This warning led to more research into Byetta and its effect on the pancreas
Compared with the GLP-1 group, the no weight loss medication group had a higher risk of progressing to wet AMD (RR, 1.45)
Insulin therapy is the administration of the hormone insulin to regulate blood glucose levels, available in various forms including rapid-acting, long-acting, and premixed options
Safety assessment Immunogenicity: Long-term use may induce antibody production
Understanding the full potential of each molecule in improving both metabolic and mechanical obesity-related complications through research will support personalised pharmacotherapy choices
Summary: GLP-1 receptor agonists do not directly increase energy but may improve perceived energy levels through better blood glucose control, weight loss, and metabolic health improvements